Onyx Biotec opened lower at ₹37.00, compared with its previous close of ₹38.00. During today's session, the stock has traded between ₹37.00 and ₹37.00, with an average traded price of ₹37.00. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 2 years ago in Onyx Biotec is now worth
₹ 6,520.00
resulting in a loss of
₹ 3,480.00 (34.80%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-1.00 (-2.63%)
Day High
₹37.00
Day Low
₹37.00
Day Open
₹37.00
Prev Close
₹38.00
Volume
4,000
Value Traded
₹0.01 Cr
1W Return
-1.33%
1M Return
-2.63%
3M Return
-4.15%
6M Return
5.41%
1Y Return
-8.43%
Market Cap (₹ Cr.)
67
PE Ratio
-316.70
PB Ratio
1.24
Dividend Yield
-
ROE
-0.39%
ROCE
1.26%
Book Value (₹)
30.56
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.33%
6 Week
-
1 Month
-2.63%
3 Month
-4.15%
9 Month
-2.63%
No data available.
Onyx Biotec promoters dispose 12.91% equity stake for ₹8.11 crore
Promoters Sanjay Jain and Fateh Pal Singh disposed of a combined 12.91% equity stake in Onyx Biotec Limited through open market sales on the NSE. The transactions, executed on June 19, 2026, amounted to a total value of ₹8.11 crore. Following the sale, Jain's holding reduced to 6.18% while Singh's stake stood at 11.57%.
3mo agoOnyx Biotec confirms no encumbrance on shares in FY26
Onyx Biotec Ltd. filed a disclosure with the National Stock Exchange of India Limited confirming no encumbrance on shares for FY26. Managing Director Sanjay Jain submitted the declaration on behalf of the promoters under SEBI Takeover Regulations.
4mo agoOnyx Biotec promoter Sanjay Jain sells 9.78% stake
Onyx Biotec promoter Sanjay Jain disposed of 1,774,000 equity shares, representing 9.78% of the company's total shareholding, on May 29, 2026. The transaction, executed on the National Stock Exchange (NSE), reduced his stake from 21.48% to 11.70%. The total value of the sale was ₹5,43,55,360.
4mo agoOnyx Biotec Managing Director and Whole Time Director resign
Onyx Biotec Ltd announced the resignation of its Managing Director Sanjay Jain and Whole Time Director Lakshya Jain, effective from the close of business hours on May 27, 2026. The resignations were approved by the company's Board based on the recommendation of the Nomination and Remuneration Committee. Both directors confirmed there are no material reasons for their departure other than those stated in their respective resignation letters.
4mo agoOnyx Biotec Reports Net Loss of ₹21.44 Lakhs in FY26 as Costs Rise; Revenue Grows to ₹6,946.94 Lakhs
Onyx Biotec Limited reported a net loss of ₹21.44 lakhs for the full year ended March 31, 2026, reversing a net profit of ₹495.42 lakhs in FY25, as total expenditure surged to ₹7,033.57 lakhs from ₹5,664.06 lakhs. Revenue from operations grew to ₹6,946.94 lakhs from ₹6,195.37 lakhs. The Board approved the audited results on May 14, 2026, with statutory auditors issuing an unmodified opinion. The company also confirmed no deviation in the utilisation of IPO proceeds of Rs. 2538.02 Lakhs raised on November 22, 2024, with total funds utilised standing at ₹2,324.51 lakhs.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 2 years ago in Onyx Biotec is now worth
₹ 6,520.00
resulting in a loss of
₹ 3,480.00 (34.80%)
Note: Past profits do not guarantee future returns.
